Matches in Wikidata for { <http://www.wikidata.org/entity/Q65391165> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q65391165 description "clinical trial" @default.
- Q65391165 description "ensayu clínicu" @default.
- Q65391165 description "klinisch onderzoek" @default.
- Q65391165 description "клінічне випробування" @default.
- Q65391165 description "կլինիկական փորձարկում" @default.
- Q65391165 name "Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients" @default.
- Q65391165 name "Efficacy and Safety of 3 Doses of BI1356" @default.
- Q65391165 type Item @default.
- Q65391165 label "Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients" @default.
- Q65391165 label "Efficacy and Safety of 3 Doses of BI1356" @default.
- Q65391165 prefLabel "Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients" @default.
- Q65391165 prefLabel "Efficacy and Safety of 3 Doses of BI1356" @default.
- Q65391165 P1050 Q65391165-C093CEF1-255F-4FF7-9CF1-C0536B701C64 @default.
- Q65391165 P1132 Q65391165-C9E74485-3103-4611-B225-301B986F180F @default.
- Q65391165 P1476 Q65391165-A8A74795-EE30-4985-890C-4A86A649701C @default.
- Q65391165 P17 Q65391165-01A62336-7A70-4F0E-AA3D-0148DDBFEE6A @default.
- Q65391165 P17 Q65391165-2BFEF11D-D78E-4015-B663-075935CBCB91 @default.
- Q65391165 P17 Q65391165-DA6FE46C-8A22-445A-9773-2B6FF88605E6 @default.
- Q65391165 P17 Q65391165-DF718619-E3D4-4163-B106-E78F3B4B33C7 @default.
- Q65391165 P17 Q65391165-E859347F-2B1D-4096-8B05-86E6E253D9A4 @default.
- Q65391165 P2899 Q65391165-69E8A255-A977-4DA5-BFDE-28596DCEEA8E @default.
- Q65391165 P3098 Q65391165-886A06F2-C4BC-4568-9ED3-692555D2203C @default.
- Q65391165 P31 Q65391165-D9FE49DC-D119-4AFA-BC50-0AC407A1911D @default.
- Q65391165 P4135 Q65391165-5B3A1227-EB3F-4F37-96BE-1F4D3FA4A052 @default.
- Q65391165 P4844 Q65391165-7E23ED17-F55B-40BE-A28C-304731CA5360 @default.
- Q65391165 P4844 Q65391165-D7FB9C01-668C-4F5A-BE11-8B1454111599 @default.
- Q65391165 P580 Q65391165-BB0A837F-7DE2-45A6-9BF8-D68B16E55B06 @default.
- Q65391165 P582 Q65391165-9C2E2CBD-EE90-4074-B9D7-0AD872CDDE68 @default.
- Q65391165 P6099 Q65391165-844380F1-01A1-4C9E-8B3A-AAF42AADC17B @default.
- Q65391165 P8363 Q65391165-554544B9-A10D-4CBD-B3A3-85B00509A2E2 @default.
- Q65391165 P1050 Q12206 @default.
- Q65391165 P1132 "+302" @default.
- Q65391165 P1476 "A Randomized, Double-blind, Placebo-controlled, Five Parallel Group Study Investigating the Efficacy and Safety of BI 1356 BS (0.5 mg, 2.5 mg and 5.0 mg Administered Orally Once Daily) Over 12 Weeks in Drug Naive and Treated Patients With Type 2 Diabetes With Insufficient Glycemic Control (Study Includes an Open-label Metformin Treatment Arm)" @default.
- Q65391165 P17 Q16 @default.
- Q65391165 P17 Q212 @default.
- Q65391165 P17 Q213 @default.
- Q65391165 P17 Q30 @default.
- Q65391165 P17 Q408 @default.
- Q65391165 P2899 "+21" @default.
- Q65391165 P3098 "NCT00328172" @default.
- Q65391165 P31 Q30612 @default.
- Q65391165 P4135 "+75" @default.
- Q65391165 P4844 Q19484 @default.
- Q65391165 P4844 Q909745 @default.
- Q65391165 P580 "2006-05-01T00:00:00Z" @default.
- Q65391165 P582 "2007-08-01T00:00:00Z" @default.
- Q65391165 P6099 Q42824440 @default.
- Q65391165 P8363 Q78089383 @default.